Form 4 for TARS Tarsus Pharmaceuticals, Inc.
Accepted 2025-12-08 00:00:00 ET · period of report 2025-12-04 · accession 0001827672-25-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-08 | 2025-12-04 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | G - Gift | $0.00 | -51.9K | 1,750 | -97% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-04 | G | D | 51,885 | $0.00 | 1,750 | D | — | — | (F1) The Reporting Person transferred 51,885 shares of common stock to the Bobak Azamian Living Trust for no consideration. The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. |